This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Percutaneous cholecystolithotomy

Authoring team

Percutaneous laparoscopic cholecystolithotomy describes a transperitoneal, laparoscopic approach to the removal of gallstones

  • patient is sedated or placed under general anaesthesia
  • laparoscope is directed to the fundus of the gallbladder by ultrasound and fluoroscopic guidance
  • viscus is punctured, a cholecystogram performed, and a guidewire inserted
  • guidewire is then used to channel metal dilators in order to widen the aperture of the perforation. Once suitably wide, a rigid endoscope is inserted into the gallbladder and stones are removed either with suction or with forceps. Large stones may be fragmented firstly using laser or ultrasound implements.

After radiology has confirmed that there are no remaining stones, a Foley catheter is sited into the gallbladder for drainage. The catheter is removed after around 10 days; the patient is discharged after 1-2 days.

Almost 80% of patients with symptomatic gallstones are suitable for treatment. Patients with thick-walled gallbladders are unsuitable as perforation is difficult.

Up to 10% of patients have recurrences of stones after percutaneous cholecystolithotomy.

Reference:

  • Cheslyn-Curtis, S. General Surgery. In: Minimal access medicine and surgery: principles and techniques. Ed. Rosin, D. (1993), Radcliffe Medical Press.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.